Title : The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial - Raskind_2004_Arch.Neurol_61_252 |
Author(s) : Raskind MA , Peskind ER , Truyen L , Kershaw P , Damaraju CV |
Ref : Archives of Neurology , 61 :252 , 2004 |
Abstract : |
PubMedSearch : Raskind_2004_Arch.Neurol_61_252 |
PubMedID: 14967774 |
Title : Pharmacologic treatments of dementia - Bonner_2002_Med.Clin.North.Am_86_657 |
Author(s) : Bonner LT , Peskind ER |
Ref : Med Clin North Am , 86 :657 , 2002 |
Abstract : |
PubMedSearch : Bonner_2002_Med.Clin.North.Am_86_657 |
PubMedID: 12171061 |
Title : Alzheimer's disease and related disorders - Raskind_2001_Med.Clin.North.Am_85_803 |
Author(s) : Raskind MA , Peskind ER |
Ref : Med Clin North Am , 85 :803 , 2001 |
Abstract : |
PubMedSearch : Raskind_2001_Med.Clin.North.Am_85_803 |
PubMedID: 11349485 |
Title : Plasma catecholamine and cardiovascular responses to physostigmine in Alzheimer's disease and aging - Petrie_2001_Psychoneuroendocrinology_26_147 |
Author(s) : Petrie EC , Peskind ER , Dobie DJ , Veith RC , Raskind MA |
Ref : Psychoneuroendocrinology , 26 :147 , 2001 |
Abstract : |
PubMedSearch : Petrie_2001_Psychoneuroendocrinology_26_147 |
PubMedID: 11087961 |
Title : Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group - Raskind_2000_Neurology_54_2261 |
Author(s) : Raskind MA , Peskind ER , Wessel T , Yuan W |
Ref : Neurology , 54 :2261 , 2000 |
Abstract : |
PubMedSearch : Raskind_2000_Neurology_54_2261 |
PubMedID: 10881250 |
Title : Pharmacologic approaches to cognitive deficits in Alzheimer's disease - Peskind_1998_J.Clin.Psychiatry_9_22 |
Author(s) : Peskind ER |
Ref : J Clin Psychiatry , 9 :22 , 1998 |
Abstract : |
PubMedSearch : Peskind_1998_J.Clin.Psychiatry_9_22 |
PubMedID: 9720483 |
Title : Hypothalamic-pituitary-adrenocortical axis responses to physostigmine: effects of Alzheimer's disease and gender - Peskind_1996_Biol.Psychiat_40_61 |
Author(s) : Peskind ER , Raskind MA , Wingerson D , Pascualy M , Thal LJ , Dobie DJ , Wilkinson CW |
Ref : Biological Psychiatry , 40 :61 , 1996 |
Abstract : |
PubMedSearch : Peskind_1996_Biol.Psychiat_40_61 |
PubMedID: 8780856 |
Title : Oral physostigmine in Alzheimer's disease: effects on norepinephrine and vasopressin in cerebrospinal fluid and plasma - Peskind_1995_Biol.Psychiat_38_532 |
Author(s) : Peskind ER , Wingerson D , Pascualy M , Thal L , Veith RC , Dorsa DM , Bodenheimer S , Raskind MA |
Ref : Biological Psychiatry , 38 :532 , 1995 |
Abstract : |
PubMedSearch : Peskind_1995_Biol.Psychiat_38_532 |
PubMedID: 8562665 |
Title : Lack of cholinergic regulation of vasopressin and norepinephrine responses to hypertonic saline in humans - Pascualy_1995_Psychoneuroendocrinology_20_679 |
Author(s) : Pascualy M , Peskind ER , Wingerson D , van Belle G , Veith RC , Dorsa DM , Raskind MA |
Ref : Psychoneuroendocrinology , 20 :679 , 1995 |
Abstract : |
PubMedSearch : Pascualy_1995_Psychoneuroendocrinology_20_679 |
PubMedID: 8848515 |